Aclaris Therapeutics (ACRS) Asset Utilization Ratio: 2018-2025
Historic Asset Utilization Ratio for Aclaris Therapeutics (ACRS) over the last 8 years, with Sep 2025 value amounting to 0.09.
- Aclaris Therapeutics' Asset Utilization Ratio fell 45.25% to 0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09, marking a year-over-year decrease of 45.25%. This contributed to the annual value of 0.09 for FY2024, which is 35.18% down from last year.
- According to the latest figures from Q3 2025, Aclaris Therapeutics' Asset Utilization Ratio is 0.09, which was down 0.44% from 0.09 recorded in Q2 2025.
- Over the past 5 years, Aclaris Therapeutics' Asset Utilization Ratio peaked at 0.19 during Q2 2024, and registered a low of 0.02 during Q2 2022.
- For the 3-year period, Aclaris Therapeutics' Asset Utilization Ratio averaged around 0.12, with its median value being 0.13 (2023).
- As far as peak fluctuations go, Aclaris Therapeutics' Asset Utilization Ratio plummeted by 71.08% in 2021, and later spiked by 450.24% in 2023.
- Aclaris Therapeutics' Asset Utilization Ratio (Quarterly) stood at 0.03 in 2021, then spiked by 333.71% to 0.11 in 2022, then surged by 31.93% to 0.15 in 2023, then crashed by 38.15% to 0.09 in 2024, then tumbled by 45.25% to 0.09 in 2025.
- Its Asset Utilization Ratio stands at 0.09 for Q3 2025, versus 0.09 for Q2 2025 and 0.08 for Q1 2025.